CURR - Sera Labs consummates exclusive distribution pact with Northern Response

The Sera Labs, a wholly owned subsidiary of CURE Pharmaceutical (OTCQB:CURR) announced its global expansion into Canada by engaging Northern Response International for the exclusive distribution of the entire plant-based, clean Seratopical Revolution skin care line. Northern Response International is a leading distributors in Canada and will be selling the line through direct-to-consumer channels and major wholesaler/retailers in the Canadian marketplace, positioning Seratopical Revolution as a masstige line.

For further details see:

Sera Labs consummates exclusive distribution pact with Northern Response